SCHEMBL550085

SCHEMBL550085

Cc1cc(NC(=O)C2CC2)ccc1N1CCC[C@]2(CCN(C3CCC(O)CC3)C2=O)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
EPHX2 P34913 2/20 0.39
GBA1 P04062 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PDE7A Q13946 1/20 0.38
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TSHR P16473 1/20 0.37
USP2 O75604 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2698098 1.00 NPC1 (0.39) NPC1RAB9AEPHX2GBA1TRPV1
SCHEMBL550084 1.00 NPC1 (0.39) NPC1RAB9AEPHX2GBA1TRPV1
SCHEMBL2698095 1.00 NPC1 (0.39) NPC1RAB9AEPHX2GBA1TRPV1
SCHEMBL550402 1.00 NPC1 (0.39) NPC1RAB9AEPHX2GBA1TRPV1
SCHEMBL550401 1.00 NPC1 (0.39) NPC1RAB9AEPHX2GBA1TRPV1
SCHEMBL551389 0.97 NPC1 (0.40) NPC1RAB9AEPHX2GBA1TRPV1
SCHEMBL551743 0.97 ALDH1A1 (0.41) NPC1RAB9AEPHX2GBA1TRPV1
SCHEMBL549275 0.97 ALDH1A1 (0.41) NPC1RAB9AEPHX2GBA1TRPV1
SCHEMBL549346 0.97 NPC1 (0.40) NPC1RAB9AEPHX2GBA1TRPV1
SCHEMBL2697855 0.97 NPC1 (0.40) NPC1RAB9AEPHX2GBA1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8563570-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2013-10-22 US claimed
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2012-05-17 US claimed
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2009-11-26 US claimed
US-8563570-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2013-10-22 US disclosed
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2012-05-17 US disclosed
US-8110581-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2012-02-07 US disclosed
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS HSD11B1, HSD11B2, HSD17B1 NPC1 722/4885RAB9A 2128/4885EPHX2 1615/4885
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS HSD11B1, HSD11B2, HSD17B1 NPC1 722/4885RAB9A 2128/4885EPHX2 1615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.